Randomized Clinical Trials
David P. Byar, Richard M Simon, William T. Friedewald et al. · New England Journal of Medicine · 1976
In spite of the controversy over the role of randomized clinical trials in medical research, the rationale underlying such trials remains persuasive as compared to recent suggestions for alternative non-randomized studies such as those relying on the use of historical controls and adjustment technics. Others have suggested that recent statistical innovations for improving clinical trials, including adaptive allocation of treatment to patients and sequential stopping procedures, are underutilized. These innovations, though theoretically interesting, are not easily adapted to large-scale, complex medical trials in which there may be multiple end points and delayed response times. Ethical considerations suggest that randomized trials are more suitable than uncontrolled experimentation in protecting the interests of patients. Randomized clinical trials remain the most reliable method for evaluating the efficacy of therapies.
Cited by 537 works. doi:10.1056/nejm197607082950204
Authors
- David P. Byar
- Richard M Simon
- William T. Friedewald
- James J. Schlesselman
- David L. DeMets
- Jonas H. Ellenberg
- Mitchell H. Gail
- James H. Ware
References
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel Procedure
- Sequential Medical Trials
- Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
- Statistical methods for the identification and use of prognostic factors
- Play the Winner Rule and the Controlled Clinical Trial
- Non-Randomized Controls in Cancer Clinical Trials
- Controlled Studies in Clinical Cancer Research
- Allocation of Subjects in Medical Experiments
- ETHICS IN COOPERATIVE CLINICAL TRIALS
- Statistics and Medical Experimentation